WeForNews | Latest News, Breaking News, News Updates Evidence of Chidambaram meeting Mukerjeas destroyed: CBI | WeForNews | Latest News, Blogs
Connect with us

India

Evidence of Chidambaram meeting Mukerjeas destroyed: CBI

Published

on

New Delhi, Sep 27 : The Central Bureau of Investigation (CBI) on Friday told the Delhi High Court that “certain evidence relating to the meeting between Chidambarams and Mukerjeas has been destroyed”.

The court was hearing the arguments on the bail plea filed by former Finance Minister and senior Congress leader P. Chidambaram in the CBI case related to INX Media, once promoted jointly by Peter and Indrani Mukerjea.

“During investigation, it has come up that Indrani and Peter Mukerjea along with some other people met P. Chidambaram. However, the records of the visitors register were destroyed,” Solicitor General Tushar Mehta told Justice Suresh Kumar Kait.

Mehta further claimed that the though the hotel visitor register has been destroyed, the details of the car by which the Mukerjeas went for the meeting with the petitioner is secure with the agency.

The agency also told the court that Indrani Mukerjea in her statement before the Magistrate said that she and her husband went to meet Chidambaram at his office where discussions were held to grant the erstwhile Foreign Investment Promotion Board (FIPB) approval to INX Media and it was conveyed to them that they will have to “take care of his son”.

Opposing the claims of the agency, senior advocate Kapil Sibal from Chidambaram’s legal team contended: “Hundreds of delegations call on the Finance Minister. I have no recollection of an INX Media delegation calling on me. Only the Visitors Log can confirm the fact. I will go by the entry in the Visitors’ Log. I am certain that I had never met Indrani at any place.”

“Sufficient evidence has come on record that the peititoner is using his position to influence the witness. Indrani is not the only one who has given a Section 164 statement, there is another witness,” the agency claimed further.

In an affidavit filed before Justice Suresh Kumar Kait, Chidambaram’s counsels on Wednesday claimed: “The said documents have been obtained by the Petitioner from his son and wife.”

The affidavit further stated that the government documents in question were a part of the Relied Upon Documents (RUD) filed by the ED in the proceedings initiated before the Adjudicating Authority in which Karti and Nalini were made defendants.

The court had on Tuesday asked Chidambaram to file an affidavit stating the source of the documents relating to the approval which were being referred to by his lawyers during the hearing of his bail plea.

Chidambaram’s legal team had also stated that denial of bail to their client would result in his “undertrial incarceration without conviction”

The agency had contended that there was sufficient evidence on record which revealed the role of the ex-Finance Minister in the INX Media case.

The agency said that if Chidambaram was released on bail, he would ensure that the crucial details pertaining to the case were not accessed by the probe agencies.

Chidambaram and his son Karti Chidambaram were named in the case by Peter and Indrani Mukerjea, who are currently in jail in Mumbai in connection with the murder of Indrani’s daughter Sheena Bora.

The ED too has filed a money laundering case against Chidambaram in this regard in 2017.

Cities

Delhi reports 51 cases of minor adverse events post vaccination

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Published

on

By

Covid 19 Vaccine

Hours after the Health Ministry announced on January 16 that India has reported no case of post-vaccination hospitalisation yet, 51 persons complained of minor adverse events in Delhi. Another person developed severe adverse event following immunization and had to be referred to the AEFI centre.

Out of a total of 4,319 healthcare and frontline workers who were vaccinated on Jnauary 16 in the National Capital, two healthcare workers at NDMC’s Charak Palika Hospital reported mild adverse event post-vaccination including mild tightness in the chest. They were kept under observation by AEFI team and discharged 30 minutes later after they felt at ease. The two other cases were reported from Northern Railway Central Hospital, of which one was referred to the AEFI centre, the Delhi government has informed.

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Beneficiaries from 11 states and union territories across India received Covishield or Covaxin shots on the first day of the vaccination drive, namely, Assam, Bihar, Delhi, Haryana, Karnataka, Maharashtra, Odisha, Rajasthan, Tamil Nadu, Telangana, and Uttar Pradesh.

Follow our coverage of the coronavirus crisis here

Continue Reading

Health

Bharat Biotech to pay compensation if Covaxin causes side-effects

The vaccine maker said in phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19

Published

on

By

COVAXIN Corona Covid vaccine

Hyderabad, January 16: Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company would pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.

In the consent form to be signed by the vaccine recipients, Bharat Biotech said: “In case of any adverse events or serious adverse events, you will be provided medically recognised standard of care in the government designated and authorised centres/hospitals.”

“The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine,” the consent form said.

In phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19. However, the clinical efficacy of the vaccine was yet to be established and it was still being studied in phase 3 clinical trials, the vaccine maker said.

“Hence it is important to appreciate that receiving the vaccine does not mean that other precautions related to COVID-19 need not be followed,” the consent form said.

According to an industry expert, the company is liable to pay compensation to people in case of serious side effects as the vaccine is being administered while in the clinical trial mode.

The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial mode.

Meanwhile, Suchitra Ella, joint managing director, Bharat Biotech International Limited, on her Twitter account said: “Covaxin & Bharat Biotech is truly humbled & honoured to be of service to the nation & the fraternity of all first responders of covid who have served public health.” — PTI

Continue Reading

Cities

AIIMS security guard reports allergy post COVID vaccination, in hospital care

Delhi has reported 52 adverse events following events of which one is serious and could involve the guard hospitalised today.

Published

on

By

Vaccine

New Delhi, January 16

A 22-year-old security guard at AIIMS, New Delhi reported allergic reaction and is learnt to be in intensive care, moments after the government said there was no post-vaccine hospitalisation.

The 22-year-old guard developed headache, rash, respiratory distress, tachycardia after vaccination. He is in ICU and his condition is stable, hospital sources said.

Delhi has reported 52 adverse events following events of which one is serious and could involve the guard hospitalised today.

All beneficiaries vaccinated at AIIMS got indigenous COVAXIN.

Continue Reading
Advertisement

Most Popular